Secondary Prevention
33
4
7
16
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.0%
1 terminated out of 33 trials
94.1%
+7.6% vs benchmark
21%
7 trials in Phase 3/4
13%
2 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (33)
National Tunisian Clinical Registry on CardioVascular Secondary Prevention Clinical
SmartWatch-driven AF Detection in Stroke Patients
The Unique and Combined Effects of Prenatal and Early Childhood Programming on Child Maltreatment: Examining Mechanisms of Change
Aspirin 50 mg vs. 100 mg in Elderly Cardiovascular Disease Patients
A Pilot Study to Assess Optimal Prevention and Outcome Improvement in Young Ischemic Stroke
Electronic Letters to Improve Patient Activation in IHD: The NUDGE-IHD Trial
triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE
The Southern-Norway Post-Stroke Atrial Fibrillation Study
Early Mobilisation of the Distal Radius Fracture
Domestic Violence Intervention to Reduce Psychological Distress and Violence Among Women Experiencing IPV in Nepal
Effectiveness of Telephysical Therapy as a Secondary Stroke Prevention Tool in Patients With Minor Stroke.
Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke
Study of Antithrombotic Treatment After IntraCerebral Haemorrhage
Secondary PRevention in Cardiovascular Disease by a Nursing Guided Program (SPRING)
Suicide Prevention Among Recipients of Care
Effectiveness of the Aktivplan Digital Intervention (ACTIVE-CaRe Pilot)
Improving Therapeutic Adherence in Cardiovascular Secondary Prevention.
Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis
Improving Cardiac Secondary Prevention
Identification of Oral Lesions Through an Autofluorescence System